The Gross Margin of EPIRUS Biopharmaceuticals Inc (EPRSQ) is 82.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2017-12-31 | 82.17% |
2016-12-31 | 82.17% |